US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

672.05

+10.021.51%

Number of Gainers:97

Number of Losers:47

Number of Flat:9

PE:- -

High:672.99

Open:662.15

Low:661.43

Close:662.00

Volume:168.41M

Turnover:4.41B

Market Cap:464.75B

Float Cap:357.29B

Loading ...

Global-E Appoints Tomer Gold as Chief Revenue Officer

THOMSON REUTERS

Edgewise Therapeutics Reports Inducement Grants as Permitted by the NASDAQ Listing Rules

THOMSON REUTERS

E-Home Household Service - Launches Project to Develop AI Service Robot for Household Services Industry

THOMSON REUTERS

Sight Sciences Hosts ASOA Live Interventional Glaucoma Dinner Series at AAO Annual Meeting

Unicycive Therapeutics Appoints Meredith Manning to Board, Names Her Nominating Committee Chair

Unicycive Therapeutics Appoints Meredith Manning to Board of Directors

THOMSON REUTERS

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

Monte Rosa Therapeutics, - to Initiate Multiple Phase 2 Studies of Mrt-8102 in High Unmet Need Indications

THOMSON REUTERS

Monte Rosa Therapeutics Announces Positive Results for Mrt-8102 in Gforce-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of Ascvd in Subjects with Elevated CVD Risk

THOMSON REUTERS

Press Release: HLS Therapeutics Announces Board of Directors Changes

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

Piper Sandler Reaffirms Their Buy Rating on Oklo Inc (OKLO)

Monte Rosa Shares Gain Ahead of Clinical Trial Review

Monte Rosa Therapeutics Shares up 18% Premarket After H.c. Wainwright Initiates Coverage with Buy Rating

THOMSON REUTERS

Coinbase Global (COIN) Wins CFTC Approval For In House Crypto Derivatives Clearing

Simply Wall St.

Monte Rosa Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $25

THOMSON REUTERS

Spend Your Holiday in Yangpu and Encounter the "One-of-a-Kind YOUNG" Charm of Light and Shadow!

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)

3 Financial Stocks Worth Watching While Short Term Rates Stay High

Simply Wall St.

Is First Patient Dosed Altering The Investment Case For Janux Therapeutics (JANX)?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK4539/news?page=25"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":672.02124,"timestamp":1791569654195,"preClose":661.99634,"halted":0,"volume":168434461,"delay":0,"changeRate":0.015143,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":10.024902,"latestTime":"10-09 14:14:14 EDT","open":662.1523,"high":672.98773,"low":661.43115,"amount":4411494192.180098,"amplitude":0.017457,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.138586,"peRate":113.608055,"turnoverRate":0.013199,"increases":97,"decrements":48,"flats":5,"marketCap":464752516549.0625,"floatMarketCap":357285832182.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":672.98773,"amplitude":0.017457,"preClose":661.99634,"low":661.43115,"pbRate":"5.138586","latestPrice":672.0493,"volume":168414305,"delay":0,"open":662.1523,"prevYearClose":881.5255,"prevWeekClose":665.7447,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":665.7447,"twentyDayClose":693.0266,"sixtyDayClose":732.057,"secType":"PLATE","market":"US","turnoverRate":0.013197,"peRate":113.608055,"marketCap":464776330115.5625,"floatMarketCap":357304665995.375,"timestamp":1791569653193,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":97,"down":47,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:25,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672754257","title":"Global-E Appoints Tomer Gold as Chief Revenue Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754257?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:01","pubTimestamp":1790856060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA7LPMYJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4220","BK4588","BK4122","BK4585","GLBE","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672754100","title":"Edgewise Therapeutics Reports Inducement Grants as Permitted by the NASDAQ Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754100?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:00","pubTimestamp":1790856006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA67DKRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EWTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672575191","title":"E-Home Household Service - Launches Project to Develop AI Service Robot for Household Services Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2672575191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672575191?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:17","pubTimestamp":1790853450,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N086:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4192","EJH","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672352751","title":"Sight Sciences Hosts ASOA Live Interventional Glaucoma Dinner Series at AAO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2672352751","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672352751?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852749,"startTime":"0","endTime":"0","summary":"Sight Sciences hosts ASOA Live interventional glaucoma dinner series at AAO annual meetingSight Sciences will showcase OMNI Ultra at the AAO annual meeting in New Orleans on Oct. 9-12, 2026.Product launch activities start Oct. 8 with an ASOA Live!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7v126L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","SG9999014039.USD","IE00BQXX3D17.EUR","BK4539","SG9999014021.USD","SGHT","IE00BQXX3F31.USD","BK4585","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BQXX3C00.GBP","SG9999014013.SGD","BK4588","LU0314104364.USD","BCDF","BK4082","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672513907","title":"Unicycive Therapeutics Appoints Meredith Manning to Board, Names Her Nominating Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2672513907","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672513907?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852739,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics appoints Meredith Manning to board, names her nominating committee chairUnicycive Therapeutics appointed Meredith Manning to its board.Manning joined the audit, compensation, no","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL422pkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","LU2065171402.SGD","BK4539","IE00BQXX3D17.EUR","BK4588","IE00BN0W2T93.GBP","LU2065170008.USD","BK4139","NDAQ","LU2210149790.SGD","LU2065171311.SGD","NBIX","IE00BGHQF748.EUR","LU0320765992.SGD","BCDF","LU0314104364.USD","IE00B3QW5Z07.USD","LU0889565916.HKD","IE00BN0W2W23.USD","LU0154245756.USD","BK4112","LU2065169927.USD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","LU2210150020.SGD","LU2324357040.USD","IE00BQXX3C00.GBP","LU0823416689.USD","LU0154245673.USD","IE00BN0W2V16.EUR","SG9999014021.USD","UNCY","IE00BQXX3F31.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751806","title":"Unicycive Therapeutics Appoints Meredith Manning to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751806","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751806?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA36Y3JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751562","title":"Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751562","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751562?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852700,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Oct.  01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3372749/0/en/sight-sciences-to-debut-the-omni-ultra-surgical-system-the-latest-technology-advancement-from-the-pioneers-of-ab-interno-canaloplasty-at-the-2026-american-academy-of-ophthalmology-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT","AFG","BK4107","BK4117","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759036","title":"Monte Rosa Therapeutics, - to Initiate Multiple Phase 2 Studies of Mrt-8102 in High Unmet Need Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759036?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUAJXMXV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672753759","title":"Monte Rosa Therapeutics Announces Positive Results for Mrt-8102 in Gforce-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of Ascvd in Subjects with Elevated CVD Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2672753759","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672753759?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUAJXMXV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751314","title":"Press Release: HLS Therapeutics Announces Board of Directors Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751314","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751314?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":"TORONTO, Oct. 1, 2026 /CNW/ -- HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS) announces the appointment of Linda Maxwell, M.D. and Mark DeLong as independent directors to its Board of Direc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672475181","title":"Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2672475181","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672475181?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct.  01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3372716/24675/en/fate-therapeutics-to-participate-in-upcoming-fourth-quarter-2026-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","FATE","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672575963","title":"Piper Sandler Reaffirms Their Buy Rating on Oklo Inc (OKLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672575963","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672575963?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:35","pubTimestamp":1790850922,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Dimple Gosai reiterated a Buy rating on Oklo Inc today and set a price target of $55.00. According to TipRanks, Gosai is rank...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-oklo-inc-oklo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-oklo-inc-oklo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKLO","BK4081","BK4539","URAN","URA","NLR","OKLS","OKLC","BK4606","OKLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672025756","title":"Monte Rosa Shares Gain Ahead of Clinical Trial Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2672025756","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672025756?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:31","pubTimestamp":1790850660,"startTime":"0","endTime":"0","summary":"Shares of Monte Rosa Therapeutics rose after the company said it will host a live conference call and webcast on Thursday at 8 a.m. Eastern to review clinical results from a recent study.The stock climbed 20%, to $14.32, in premarket trading Thursday. Through Wednesday's close, shares are down 22% year to date.The biotechnology company late Wednesday said it will review clinical results from an early-stage study of its in-development treatment--called MRT-8102, a molecular glue degrader--in patients with elevated risk of cardiovascular disease.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","GLUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672292756","title":"Monte Rosa Therapeutics Shares up 18% Premarket After H.c. Wainwright Initiates Coverage with Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672292756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672292756?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:25","pubTimestamp":1790850312,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4N45N0NI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759098","title":"Coinbase Global (COIN) Wins CFTC Approval For In House Crypto Derivatives Clearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759098","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759098?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:14","pubTimestamp":1790849661,"startTime":"0","endTime":"0","summary":"Coinbase Global (NasdaqGS:COIN) received CFTC approval for Coinbase Clearing LLC as a Derivatives Clearing Organization in the U.S.\nThe registration lets Coinbase internally clear and settle crypto futures, options on futures, and swaps for its U.S. clients.\nCoinbase plans to support 24/7 settlement using stablecoins such as USDC and reduce reliance on external clearing firms.\nThe new CFTC clearing approval for Coinbase sits alongside wider trends our research has identified for the...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/1033402-choice1-card/1788934404557","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/1033402-choice1-card/1788934404557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-coin/coinbase-global/news/coinbase-global-coin-wins-cftc-approval-for-in-house-crypto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-coin/coinbase-global/news/coinbase-global-coin-wins-cftc-approval-for-in-house-crypto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4596","FIAT","FINX","BK4539","COIG","BK4551","COYY","09711","07711","CONX","BK4516","BK4595","ICOI","BK4535","CONI","BK4600","COIX","COIW","COIN","FDIG","07311","IBLC","LU1861217088.USD","LU1861220207.SGD","BK4585","COIO","BK4588","LU2360107671.USD","BK4554","CONL","09311","LU1861558580.USD","BK4112","CONY","LU1861559042.SGD","COIA","COII","BLCK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672575665","title":"Monte Rosa Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2672575665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672575665?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:08","pubTimestamp":1790849322,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nAZN4TN2P8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","GLUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177907942","title":"Spend Your Holiday in Yangpu and Encounter the \"One-of-a-Kind YOUNG\" Charm of Light and Shadow!","url":"https://stock-news.laohu8.com/highlight/detail?id=1177907942","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177907942?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:51","pubTimestamp":1790848290,"startTime":"0","endTime":"0","summary":"Still not sure where to go for the National Day holiday? Just want a relaxed, easy photo-spotting trip? Then Yangpu is the right place for you.From September 27 to October 6, the Yangpu sub-venue of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","YOU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672755431","title":"Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755431?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:20","pubTimestamp":1790846446,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-absci-absi-summit-therapeutics-smmt-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-absci-absi-summit-therapeutics-smmt-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","ABSI","BK4539","BK4585","XBI","BK4137","LU2488822045.USD","BK4581","ARKG","SMMT","STRO","XLV","HCSG","BK4121","LABU","LU0029874061.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672730516","title":"3 Financial Stocks Worth Watching While Short Term Rates Stay High","url":"https://stock-news.laohu8.com/highlight/detail?id=2672730516","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672730516?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:20","pubTimestamp":1790835644,"startTime":"0","endTime":"0","summary":"Short term interest rates are high, inflation is easing but still in focus, and the Fed is hinting that borrowing costs could stay elevated for longer, which quietly shifts power toward companies that live and breathe cash management and short duration assets. That mix can create real opportunities for investors who understand where the money is parked. This article breaks down three stocks from our screener that appear well aligned with this rate driven story.\nThe three stocks in this...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/7132000-choice2-card/1788989255366","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/7132000-choice2-card/1788989255366"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-hood/robinhood-markets/news/3-financial-stocks-worth-watching-while-short-term-rates-sta","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-hood/robinhood-markets/news/3-financial-stocks-worth-watching-while-short-term-rates-sta","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B64PRP62.GBP","HOYY","BK4588","BPAY","BK4227","BK4547","HOII","LU0106831901.USD","BK4135","LU1668664300.SGD","BK4535","HODU","LU1861559042.SGD","LU1861558580.USD","FINX","IE00BGHQF748.EUR","BK4585","BK4106","HOOW","HOOY","BK4551","PAYO","IE00B3QW5Z07.USD","BLCK","HOOZ","LU1791807156.HKD","BK4539","CRPT","ROBN","HOOG","HOOC","HOOI","LU2108987350.USD","HOOX","HOOD","BK4127","AMP","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672305087","title":"Is First Patient Dosed Altering The Investment Case For Janux Therapeutics (JANX)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672305087","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672305087?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:17","pubTimestamp":1790835439,"startTime":"0","endTime":"0","summary":"Janux Therapeutics recently treated the first patient in a Phase 1 study that combines its prostate cancer candidates JANX013 and JANX007 in metastatic castration-resistant disease, marking a new clinical step for its precision oncology platform.\nThis dual-asset trial signals that Janux Therapeutics is testing its modular prostate cancer franchise in a harder to treat setting, which could shape how investors view the breadth and scalability of its drug development approach.\nThe focus now...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-janx/janux-therapeutics/news/is-first-patient-dosed-altering-the-investment-case-for-janu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-janx/janux-therapeutics/news/is-first-patient-dosed-altering-the-investment-case-for-janu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JANX","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":25,"totalSize":797,"code":"91000000","status":"200"}]}}